Natural killer cell mediated cytotoxic responses in the tasmanian devil

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Brown, Gabriella K ^a   Kreiss, Alexandre ^a   Lyons, A Bruce ^b   Woods, Gregory M ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; ANTISERUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARNIVORE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DEVIL FACIAL TUMOR DISEASE; FACE TUMOR; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SARCOPHILUS HARRISII; ANIMAL; ANIMAL DISEASE; ANIMAL PARASITOSIS; CELL STRAIN K 562; IMMUNOLOGY; MARSUPIAL; NATURAL KILLER CELL; NEOPLASM; PATHOLOGY; TIME;

METATHERIA; SARCOPHILUS HARRISII;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNE SERA; IMMUNIZATION; K562 CELLS; KILLER CELLS, NATURAL; MARSUPIALIA; NEOPLASMS; PARASITIC DISEASES, ANIMAL; TIME FACTORS;

EID: 80052997010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024475     Document Type: Article

References (32)

1. Hawkins CE, Baars C, Hesterman H, Hocking GJ, Jones ME, et al. (2006) Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii. Biol Conserv 131: 307-324.
2. Pearse AM, Swift K, (2006) Allograft theory: transmission of devil facial-tumour disease. Nature 439: 549.
3. Woods GM, Kreiss A, Belov K, Siddle H, Obendorf DL, et al. (2007) The immune response of the Tasmanian Devil (Sarcophilus harrisii) and Devil Facial Tumour Disease. EcoHealth 4: 338-345.
4. Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, et al. (2010) The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 327: 84-87.
5. Loh R, Hayes D, Mahjoor A, O'Hara A, Pyecroft S, et al. (2006 b) The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii). Vet Pathol 43: 896-903.
6. Kreiss A, Fox N, Bergfeld J, Quinn SJ, Pyecroft S, et al. (2008) Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii). Dev & Comp Immunol 32: 544-553.
7. Griner LA, (1979) Neoplasms in Tasmanian Devils (Sarcophilus harrisii). J Natl Cancer Inst 62: 589-593.
8. Lozzio BB, Lozzio CB, (1979) Properties and usefulness of the original K-562 Human myelogenous leukemia cell line. Leuk Res 3: 363-370.
9. Torri G, (2010) Inhalation anesthetics: a review. Minerva Anestesiol 76: 215.
10. Hathcock KS, (1992) T cell enrichment by nonadherence to nylon. In: Coligan JE, Kruisbeek AM, Nargulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology pp. 3.2.1-3.2.4.
11. Horwitz DA, Bakke AC, Abo W, Nishiya K, (1984) Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol 132: 2370-2374.
12. Julius MH, Simpson E, Herzenberg LA, (1973) A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3: 645-649.
13. Avril T, Jarousseau A-C, Watier H, Boucraut J, Le Bouteiller P, et al. (1999) Trophoblast Cell Line Resistance to NK Lysis Mainly Involves an HLA Class I-Independent Mechanism. J Immunol 162: 5902-5909.
14. Lachish S, Jones ME, McCallum H, (2007) The impact of disease on the survival and population growth rate of the Tasmanian devil. J Anim Ecol 76: 926-936.
15. de Castro F, Bolker B, (2005) Mechanisms of disease-induced extinction. Ecol Lett 8: 117-126.
16. McCallum H, Tompkins DM, Jones ME, Lachish S, Marvanek S, et al. (2007) Distribution and impacts of Tasmanian devil facial tumor disease. EcoHealth 4: 318-325.
17. Loh R, Bergfeld J, Hayes D, O'Hara A, Pyecroft S, et al. (2006 a) The Pathology of Devil Facial Tumor Disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii). Vet Pathol 43: 890-895.
18. Siddle H, Kreiss A, Eldridge MD, Noonan E, Clarke CJ, et al. (2007) Transmission of a fatal clonal tumour by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc Natl Acad Sci USA 104: 16221-16226.
19. Keaney MA, Hirte H, McPhail S, Fernando L, Belanger R, et al. (1979) The antibody-dependent cell-mediated cytotoxic reaction. I. The morphological and functional heterogeneity of the rabbit cytotoxic cells. Immunology 38: 665-676.
20. Grewal AS, Rouse BT, Babiuk LA, (1977) Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun 15: 698-703.
21. Kumagai K, Itoh K, Suzuki R, Hinuma S, Saitoh F, (1982) Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities. J Immunol 129: 388.
22. Nelson DL, Bundy BM, Pitchon HE, Blaese RM, Strober W, (1976) The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol 117: 1472-1481.
23. Fukui H, Overton WR, Herberman RB, Reynolds CW, (1987) Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities. J Leukoc Biol 41: 130-142.
24. Stockmeyer B, Beyer T, Neuhuber W, Repp R, Kalden JR, et al. (2003) Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells. J Immunol 171: 5124-5129.
25. Carson WE, Parihar R, Lindemann MJ, Personeni N, Dierksheide J, et al. (2001) Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells. Eur J Immunol 31: 3016-3025.
26. Leighton F, Artois M, Capucci L, Gavier-Widen D, Morisse J, (1995) Antibody response to rabbit viral hemorrhagic disease virus in red foxes (Vulpes vulpes) consuming livers of infected rabbits (Oryctolagus cuniculus). J Wildl Dis 31: 541-544.
27. Kreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM, (2009) A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian Devil. Anat Rec 292: 611-620.
28. Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, et al. (2004) Rituximab-dependent cytotoxicity by natural killer cells: Influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res 64: 4664-4669.
29. Fayngerts SA, Najakshin AM, Taranin AV, (2007) Species-specific evolution of the FcR family in endothermic vertebrates. Immunogenetics 59: 493-506.
30. Jones ME, Patekau D, Geffen E, Moritz C, (2004) Genetic diversity and population structure of Tasmanian devils, the largest marsupial carnivore. Mol Ecol 13: 2197-2209.
31. Siddle H, Sanderson C, Belov K, (2007) Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii). Immunogenetics 59: 753-760.
32. O'Neill ID, (2010) Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy. Int J Cancer 127: 1637-1642.